187 related articles for article (PubMed ID: 6160325)
1. Labetalol in essential hypertension.
Larochelle P; Hamet P; Hoffman B; Kuchel O; McKenzie J; Mitenko P; Ogilvie RI; Ruedy J
J Cardiovasc Pharmacol; 1980; 2(6):751-9. PubMed ID: 6160325
[TBL] [Abstract][Full Text] [Related]
2. Monotherapy with labetalol in the treatment of mild hypertension: a double-blind study.
Davidov ME; Moir GD; Poland MP; Maloy J; Medakovic M
Am J Med; 1983 Oct; 75(4A):47-53. PubMed ID: 6356899
[TBL] [Abstract][Full Text] [Related]
3. Double-blind trial of labetalol.
Kane J; Gregg I; Richards DA
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):737-41. PubMed ID: 791329
[TBL] [Abstract][Full Text] [Related]
4. Step II treatment with labetalol for essential hypertension.
Bloomfield SS; Lucas CP; Gantt CL; Poland MP; Medakovic M
Am J Med; 1983 Oct; 75(4A):81-6. PubMed ID: 6356902
[TBL] [Abstract][Full Text] [Related]
5. Multiclinic comparison of labetalol to metoprolol in treatment of mild to moderate systemic hypertension.
Frishman WH; Michelson EL; Johnson BF; Poland MP
Am J Med; 1983 Oct; 75(4A):54-67. PubMed ID: 6356900
[TBL] [Abstract][Full Text] [Related]
6. Effect of increasing doses of labetalol on blood pressure, plasma renin activity and aldosterone in hypertensive patients.
Salvetti A; Pedrinelli R; Sassano P; Arzilli F
Clin Sci (Lond); 1979 Dec; 57 Suppl 5():401s-404s. PubMed ID: 396086
[TBL] [Abstract][Full Text] [Related]
7. Controlled comparison of labetalol and propranolol in the management of severe hypertension.
Pugsley DJ; Armstrong BK; Nassim MA; Beilin LJ
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):777-82. PubMed ID: 791331
[TBL] [Abstract][Full Text] [Related]
8. [Effects of labetalol, a new alpha- and beta-adrenoreceptor blocking drug, on arterial pressure, renal function and renin activity (author's transl)].
Zech P; Pozet N; Sassard J; Vincent M
Nouv Presse Med; 1980 Mar; 9(15):1087-90. PubMed ID: 7008020
[TBL] [Abstract][Full Text] [Related]
9. The treatment of hypertension by labetalol--a new alpha- and beta-adrenoreceptor blocking agent.
Stern N; Teicher A; Rosenthal T
Clin Cardiol; 1982 Feb; 5(2):125-30. PubMed ID: 7039899
[TBL] [Abstract][Full Text] [Related]
10. Sympathetic nervous activity and the pressor effect of noradrenaline under chronic alpha-beta-adrenoceptor blockade with labetalol in hypertension.
Zschiedrich H; Neurohr W; Lüth JB; Philipp T; Distler A
Klin Wochenschr; 1983 Jul; 61(13):661-7. PubMed ID: 6310204
[TBL] [Abstract][Full Text] [Related]
11. Antihypertensive and metabolic effects of increasing doses of atenolol and labetalol. A comparative study in primary hypertension.
Nilsson OR; Karlberg BE; Henningsen NC; Thulin T
Acta Med Scand Suppl; 1982; 665():117-9. PubMed ID: 6760679
[TBL] [Abstract][Full Text] [Related]
12. Multicenter clinical evaluation of long-term efficacy and safety of labetalol in treatment of hypertension.
Michelson EL; Frishman WH; Lewis JE; Edwards WT; Flanigan WJ; Bloomfield SS; Johnson BF; Lucas C; Freis ED; Finnerty FA
Am J Med; 1983 Oct; 75(4A):68-80. PubMed ID: 6356901
[TBL] [Abstract][Full Text] [Related]
13. Labetalol and hydrochlorothiazide in hypertension. Labetalol/Hydrochlorothiazide Multicenter Study Group.
Clin Pharmacol Ther; 1985 Jul; 38(1):24-7. PubMed ID: 2860990
[TBL] [Abstract][Full Text] [Related]
14. Intravenous labetalol in the treatment of severe hypertension and hypertensive emergencies.
Wilson DJ; Wallin JD; Vlachakis ND; Freis ED; Vidt DG; Michelson EL; Langford HG; Flamenbaum W; Poland MP
Am J Med; 1983 Oct; 75(4A):95-102. PubMed ID: 6139020
[TBL] [Abstract][Full Text] [Related]
15. Combined alpha- and beta-receptor inhibition in the treatment of hypertension.
Prichard BN
Drugs; 1984; 28 Suppl 2():51-68. PubMed ID: 6151891
[TBL] [Abstract][Full Text] [Related]
16. Hemodynamic effects of labetalol, an alpha and beta adrenergic blocking agent, in hypertensive subjects.
Mehta J; Cohn JN
Circulation; 1977 Feb; 55(2):370-5. PubMed ID: 12880
[TBL] [Abstract][Full Text] [Related]
17. Labetalol in long-term treatment of hypertension.
Prichard BN; Boakes AJ
Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):743-50. PubMed ID: 62582
[TBL] [Abstract][Full Text] [Related]
18. Comparative trial of labetalol and acebutolol, alone or associated with dihydralazine, in treatment of essential hypertension.
Thibonnier M; Lardoux MD; Corvol P
Br J Clin Pharmacol; 1980 Jun; 9(6):561-7. PubMed ID: 6992823
[TBL] [Abstract][Full Text] [Related]
19. Use of labetalol in moderate to severe hypertension.
Macdonald I; Hua AS; Thomas GW; Woo KT; Whitworth JA; Kincaid-Smith P
Med J Aust; 1980 Apr; 1(7):325-7. PubMed ID: 7393061
[TBL] [Abstract][Full Text] [Related]
20. Dose-response evaluation of oral labetalol in patients presenting to the emergency department with accelerated hypertension.
Gonzalez ER; Peterson MA; Racht EM; Ornato JP; Due DL
Ann Emerg Med; 1991 Apr; 20(4):333-8. PubMed ID: 2003657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
